STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM - KERYX BIOPHARMACEUTICALS INC ownership

KERYX BIOPHARMACEUTICALS INC's ticker is KERX and the CUSIP is 492515101. A total of 136 filers reported holding KERYX BIOPHARMACEUTICALS INC in Q2 2014. The put-call ratio across all filers is 0.74 and the average weighting 0.2%.

Quarter-by-quarter ownership
STATE BOARD OF ADMINISTRATION OF FLORIDA RETIREMENT SYSTEM ownership history of KERYX BIOPHARMACEUTICALS INC
ValueSharesWeighting
Q3 2018$220,000
-9.8%
64,7820.0%0.00%0.0%
Q2 2018$244,000
-7.9%
64,7820.0%0.00%0.0%
Q1 2018$265,000
-12.0%
64,7820.0%0.00%0.0%
Q4 2017$301,000
-34.6%
64,7820.0%0.00%0.0%
Q3 2017$460,000
-1.7%
64,7820.0%0.00%0.0%
Q2 2017$468,000
+17.3%
64,7820.0%0.00%0.0%
Q1 2017$399,000
+5.0%
64,7820.0%0.00%0.0%
Q4 2016$380,000
+10.5%
64,7820.0%0.00%0.0%
Q3 2016$344,000
-19.8%
64,7820.0%0.00%0.0%
Q2 2016$429,000
+41.6%
64,7820.0%0.00%0.0%
Q1 2016$303,000
-7.3%
64,7820.0%0.00%0.0%
Q4 2015$327,000
+43.4%
64,7820.0%0.00%0.0%
Q3 2015$228,000
-64.6%
64,782
+0.4%
0.00%
-50.0%
Q2 2015$644,000
-21.6%
64,5020.0%0.00%
-33.3%
Q1 2015$821,000
-8.4%
64,502
+1.9%
0.00%0.0%
Q4 2014$896,000
+2.9%
63,3270.0%0.00%0.0%
Q3 2014$871,000
-10.6%
63,3270.0%0.00%0.0%
Q2 2014$974,000
+2.1%
63,327
+13.2%
0.00%0.0%
Q1 2014$954,000
+31.6%
55,9580.0%0.00%
+50.0%
Q4 2013$725,000
+28.3%
55,9580.0%0.00%0.0%
Q3 2013$565,000
+35.2%
55,9580.0%0.00%
+100.0%
Q2 2013$418,00055,9580.00%
Other shareholders
KERYX BIOPHARMACEUTICALS INC shareholders Q2 2014
NameSharesValueWeighting ↓
VHCP Management, LLC 700,273$10,770,0005.76%
HARVEY CAPITAL MANAGEMENT INC 932,400$14,340,0005.13%
Camber Capital Management LP 3,000,000$46,140,0003.02%
Baupost Group 10,539,986$162,105,0002.64%
SECTORAL ASSET MANAGEMENT INC 3,741,656$57,547,0002.44%
DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C) 3,884,409$59,742,0002.40%
Knoll Capital Management, LLC 200,000$3,076,0001.37%
DAFNA Capital Management LLC 92,400$1,421,0001.35%
NORTHPOINTE CAPITAL LLC 892,011$13,719,0001.32%
Rhenman & Partners Asset Management AB 240,000$3,691,0001.10%
View complete list of KERYX BIOPHARMACEUTICALS INC shareholders